个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
王星，博士、副教授、硕士生导师，北京市教委青年拔尖人才。从事中药有效成分发现、作用机制及中药药性理论科学内涵研究。先后主持国家自然科学基金、北京市自然科学基金、北京市高校青年拔尖人才培育计划等多项课题，以第一或通讯作者发表研究论文30余篇，其中SCI收录13篇，获李时珍医药创新奖，获国家发明专利1项。先后培养硕士研究生4人，其中2人顺利毕业，1人获硕士研究生国家奖学金；指导4名本科生获得第九届全国大学生基础医学创新研究暨实验设计论坛总决赛金奖。担任世界中医药学会联合会中药系统科学与工程专业委员会常务理事等。
1) 国家自然科学基金面上项目——基于“肺苦味受体-巨噬细胞-炎性微环境”路径研究清肺排毒汤“苦泄”治疗肺炎的作用及机制（No. 82374112，起讫时间：2024.01-2027.12）
2) 首都医科大学中医药学院前瞻性研究方向孵育项目——中药“五味”药性理论调控机理探索：以苦味受体（T2Rs）为例（起讫时间：2021.01-2025.12）
3) 国家自然科学基金青年基金项目——苦味平喘中药抗哮喘有效成分辨识及与苦味药性相关性研究（No. 81603311，起讫时间：2017.01-2019.12）
4) 北京市自然科学基金青年基金项目——中药“苦能降气”科学内涵阐释——定喘汤降肺气有效成分辨识及与苦味药性关联机制研究（No. 7164239，起讫时间：2016.01-2017.12）
5) 北京市属高校青年拔尖人才培育计划——麻杏石甘汤苦味抗哮喘有效成分辨识及其“苦降肺气”科学内涵研究（No. CIT&TCD201804084，起讫时间：2018.01-2020.12）
1) 国家自然科学基金面上项目——基于“肺苦味受体-巨噬细胞-炎性微环境”路径研究清肺排毒汤“苦泄”治疗肺炎的作用及机制（No. 82374112，起讫时间：2024.01-2027.12）
2) 首都医科大学中医药学院前瞻性研究方向孵育项目——中药“五味”药性理论调控机理探索：以苦味受体（T2Rs）为例（起讫时间：2021.01-2025.12）
3) 国家自然科学基金青年基金项目——苦味平喘中药抗哮喘有效成分辨识及与苦味药性相关性研究（No. 81603311，起讫时间：2017.01-2019.12）
4) 北京市自然科学基金青年基金项目——中药“苦能降气”科学内涵阐释——定喘汤降肺气有效成分辨识及与苦味药性关联机制研究（No. 7164239，起讫时间：2016.01-2017.12）
5) 北京市属高校青年拔尖人才培育计划——麻杏石甘汤苦味抗哮喘有效成分辨识及其“苦降肺气”科学内涵研究（No. CIT&TCD201804084，起讫时间：2018.01-2020.12）
一、发表论文
[1] Yatong Li#,Yuxin Zhang#, Xia Wu, YanbinGao, Junfang Guo, Yulang Tian, Ziyue Lin, Xing Wang*. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine usingvirtual Screening, biological evaluation and molecular dynamics studies. Bioorganic Chemistry, 2021, 115: 105197.
[2] Xiaoxi Li, Yatong Li, Wenwen Zhao, Lan Yu, Xiaolu Hu,Yimeng Zhao, Qiang Guo, Xing Wang*, Xia Wu*. Dihydroflavonoids asBioactive Components of Penthorum chinense, a Miao Ethnomedicine, against NAFLD through Bile Acid Metabolism Pathway. Chemistry & Biodiversity.2022 May;19(5):e202200146.
[3] Liangtao Luo, Haowen Wang, Guowei Huang, Lu Zhang, XiuweiLi, Chongyang Ma*, Xing Wang*. Pharmacological Mechanisms of Tingliziagainst Chronic Heart Failure Determined by Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine,2022. doi: 10.1155/2022/2152399. eCollection2022.
[4] Junfang Guo, Zhongqi Ning, Xia Wu, Yanjiang Qiao*, XingWang*. Discovery of a natural PI3Kδ inhibitor through virtual screening andbiological assay study. Biochemical and Biophysical Research Communications, 2019, 508(3): 709-714.
[5] Xing Wang,Junfang Guo, Zhongqi Ning, Xia Wu*. Discoveryof a Natural Syk Inhibitor from Chinese Medicine through a Docking-BasedVirtual Screening and Biological Assay Study. Molecules, 2018, 23(12): 3114.
[6] Xing Wang#*, Yuxin Zhang#, Ying Yang, Xia Wu, Hantian Fan, YanjiangQiao*. Identification of berberine as a directthrombin inhibitor from traditional Chinese medicine through structural,functional and binding studies. Scientific Reports,2017. 7: 44040.
[7] YuxinZhang#, Xing Wang#, Li Xi,Sha Peng, Shifeng Wang, Christopher Huang, Corine Huang, Qiao Zhang, Dai Li,Jun Jiang, Qin Ouyang, Yanling Zhang, Shiyou Li*,YanjiangQiao*.Identification of a specific agonist of human TAS2R14 from Radix Bupleuri through virtual screening, functional evaluation andbinding studies. ScientificReports, 2017. 7(1): 12174.
[8] XingWang, Yuxin Zhang, Qing Liu,Zhixin Ai, Yanling Zhang, Yuhong Xiang, Yanjiang Qiao*. Discovery of DualETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silicoand in Vitro Screening. International journal of molecular sciences,2016. 17(3): 389.
[9] HantianFan, Junfang Guo, Yuxi Gu, Zhongqi Ning, Yuxin Zhang, Yanjiang Qiao, Xing Wang*. Rationalsearch for PDE10A inhibitors from Sophoraflavescens roots using pharmacophore- and docking-based virtual screening. Molecular Medicine Reports, 2017. 17(1): 388-393.
[10] Yuxin Zhang#, XingWang#, Shifeng Wang, YanLing Zhang*, Yan-Jiang Qiao*. TraditionalChinese Bitter Flavor theory Is there any relation with taste type II receptors. European Journal of IntegrativeMedicine, 2016. 8(6): 980-990.
[11] 王晓艳，李伟霞，张辉，冯科冉，张明亮，吴娅丽，陈毓龙，李琨，王星*，唐进法*.基于分子对接和实验验证的五味子乙素在人肝微粒体中的代谢酶表型研究.中药药理与临床,2023, 39(03): 47-52.
[12] YuxinZhang#, Xing Wang#, Binan Lu, Yanbin Gao, YanlingZhang, Yatong Li, Hongjuan Niu, Lu Fan, Zongran Pang*, Yanjiang Qiao*.Functional and binding studies of gallic acid showing platelet aggregationinhibitory effect as a thrombin inhibitor. Chinese Herbal Medicines,2022, 14(2): 303-309.
[13] Yuxin Zhang #, Xing Wang #, Shifeng Wang, Zhang Qiao, Peng Sha, Li Xi,Yanling Zhang*, Yanliang Qiao *. In silico investigation of the association ofthe TRPM8 ion channel with the pungent flavor of Chinese herbs. Journal of Traditional Chinese MedicalSciences, 2016, 3(4): 248-255.
[14] Wei-Wei Guo, Feng Qiu, Xiao-Qing Chen, Yin-Ying Ba, Xing Wang, Xia Wua. In-vivo absorption ofpinocembrin-7-O-beta-D-glucoside in rats and its in-vitro biotransformation. Scientific Reports, 2016. 6: 29340.
[15] Ping Su,Hongyu Guan, Yifeng Zhang, Xing Wang, Linhui Gao, Yujun Zhao, Tianyuan Hu, JiaweiZhou, Baowei Ma, Lichan Tu, Yuru Tong, Luqi Huang and Wei Gao. Probing thesingle key amino acid responsible for the novel catalytic function ofent-kaurene oxidase supported by NADPH-cytochrome P450 reductases in Tripterygiumwilfordii[J]. Frontiers in Plant Science, 2017, 8: 1756.
[16] 张宇昕，王星，刘青，翟晨曦，栗世铀，乔延江. 内源表达T2R38受体活化方法的构建及其在中药苦味药性研究应用中的探讨[J]. 中华中医药杂志,2016,10:3981-3984.
二、授权专利
银杏酸在制备预防和/或治疗过敏性疾病的产品中的应用. 发明人：王星，张宇昕，乔延江. 专利权人：首都医科大学。专利授权号：ZL201710599259.6。授权时间：2020.10.02.
文件上传中...
